When was MicroVention founded?

MicroVention was founded in 1997.

Where is MicroVention located?

MicroVention is headquartered in Tustin, United States. It is registered at SUITE 3, THE BARRACKS BUILDING,CLIFFORDS FORT,NORTH SHIELDS,TYNE AND WEAR,NE30 1JE.

How many employees does MicroVention have?

As of May 31, 2026, the latest employee count at MicroVention is 1806.

Is MicroVention a funded company?

MicroVention is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of MicroVention?

Annual revenue of MicroVention is between £10M and £50M as on Mar 31, 2025

Where does MicroVention rank among its competitors?

MicroVention ranks 7th amongst 54 active competitors, of which 19 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was XCath, which secured $30M in Mar, 2026.

Who are the top competitors of MicroVention?

MicroVention's top competitors include Rapid Medical, Penumbra and Anaconda Biomed. Among them, XCath secured the most recent funding round in March, 2026.

MicroVention - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Innovative neurovascular solutions for hemorrhagic and ischemic stroke treatment. They develop and market minimally invasive neuroendovascular technologies, offering therapeutic advantages for neurovascular disorders. Their comprehensive portfolio includes devices for treating aneurysms, neurovascular malformations, ischemic stroke, and carotid artery disease. They provide access products like catheters and guidewires. They focus on advancing physician practice and improving patient outcomes through innovation in neurovascular care. They are committed to creating technologies that improve patients' lives. They are a medical device company.

Website: microvention.com
Registered Address: SUITE 3, THE BARRACKS BUILDING,CLIFFORDS FORT,NORTH SHIELDS,TYNE AND WEAR,NE30 1JE

Key Metrics

Founded Year

1997

Location

Tustin, United States

Stage

Acquired

Investors

Domain Associates & 5 more

Ranked

7^th among 54 active competitors

Annual Revenue

£10M - £50M as on Mar 31, 2025

Employee Count

1,806 as on May 31, 2026

Investment & Acquisitions

Okami Medical

Similar Companies

Rapid Medical & 47 more

Exit Details

Acquired by Terumo Medical (Feb 28, 2006)

View MicroVention's full profile

MicroVention is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MICROVENTION UK LIMITED CIN: 4492546 , United Kingdom, Active	Jul 22, 2002	£10M - £50M (As on Mar 31, 2025)	15 (As on Mar 31, 2025)

MicroVention got acquired by Terumo Medical on Feb 28, 2006.

Click here to take a look at MicroVention's acquisition in detail

MicroVention is a funded company. MicroVention has 6 institutional investors.

View details of MicroVention's funding rounds and investors

MicroVention's employee count trend

MicroVention has 1,806 employees as of May 26. Here is MicroVention's employee count trend over the years:

Uncover MicroVention's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MicroVention include Rapid Medical, Penumbra and Anaconda Biomed. Here is the list of Top 10 competitors of MicroVention, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Rapid Medical 2008, Yokneam Illit (Israel), Series D	Developer of neurovascular interventional devices such as distal access & microcatheters	$79M	MicroPort Orthopedics, BRM & 9 others	64/100
2nd	Penumbra 2004, Alameda (United States), Acquired	Developer of medical devices for neurovascular and peripheral thrombectomy	$121K	Novo Holdings, The Angels’ Forum & 4 others	63/100
3rd	Anaconda Biomed 2015, Barcelona (Spain), Series B	Developer of medical devices for mechanical thromboectomy procedures	$39M	Omega Funds, Ysios Capital & 6 others	55/100
4th	XCath 2017, Houston (United States), Series C	Developer of endovascular robotics and steerable guidewires	$92M	Crescent Enterprises & 1 others	49/100
5th	Sequent Medical 2007, Aliso Viejo (United States), Acquired	Catheter-based neurovascular devices	$65.3M	Delphi Ventures, Versant Ventures & 4 others	48/100
6th	Terumo Neuro 1997, Aliso Viejo (United States), Unfunded	Developer of minimally-invasive devices for the treatment of vascular diseases in the brain	-	-	46/100
7th	MicroVention 1997, Tustin (United States), Acquired	Innovative neurovascular solutions for hemorrhagic and ischemic stroke treatment	-	Domain Associates, Advanced Technology Ventures ... & 4 others	45/100
8th	BrainsGate 2000, Caesarea (Israel), Series F	Electrical stimulation therapy for CNS diseases	$97M	BNP Paribas, Cipio Partners & 11 others	44/100
9th	Galaxy Therapeutics 2012, Milpitas (United States), Funding Raised	Developer of neurovascular devices to treat brain aneurysms	-	National Science Foundation	44/100
10th	N Focus Neuro 2007, Palo Alto (United States), Acquired	Endovascular neurosurgery solutions for the treatment of intracranial aneurysms	$37M	VentureHealth, Endeavour Vision & 5 others	43/100